{"id":"W2143559032","doi":"10.1056/nejmoa1010494","title":"Boceprevir for Untreated Chronic HCV Genotype 1 Infection","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2502,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Genentech; Gilead Sciences; Valeant Pharmaceuticals International; Sanofi; GlaxoSmithKline; Pfizer; Bristol-Myers Squibb","keywords":"Boceprevir; Medicine; Ribavirin; Hepatitis C virus; Genotype; Virology; Telaprevir; Protease inhibitor (pharmacology); Chronic hepatitis; Virus; Internal medicine; Immunology; Viral load; Gene; Antiretroviral therapy; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}